Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Berry Genomics Co.,Ltd
No Price
Closing Price XSHE 29.04.2026:
9,92 CNY
29.04.2026 07:04
Current Prices from Berry Genomics Co.,Ltd
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
SHENZHEN STOCK EXCHANGE
000710.SZ
CNY
29.04.2026 07:04
9,92 CNY
0,17 CNY
+1,74 %
Share Float & Liquidity
Free Float88,68 %
Shares Float313,52 M
Shares Outstanding353,52 M
Company Profile for Berry Genomics Co.,Ltd Share
Berry Genomics Co.,Ltd, a genomics company, develops and commercializes technologies for the life sciences and clinical applications in China. The company offers NGS- based tests for various genetic diseases and cancers from preconception to adulthood; WES test for inherited pathogenic mutations in the GCH1 gene associated with the metabolic disease Dopa-responsive dystonia; CNV-Seq test for indicating translocation at the end of chromosomes 2 and 8; RNA-Seq test to demonstrate the photo-induced protein dimerization of plant cryptochromes; and WGS test for genome wide detection of DNA variants, including SNP, CNV, Indel, and SV. It serves approximately 2,000 hospitals throughout Mainland China, Hong Kong, Macao, and Taiwan. The company serves various organizations and facilities, including hospitals, research institutions, universities, and corporations. Berry Genomics Co.,Ltd has a partnership with Personalis, Inc. The company was founded in 2010 and is headquartered in Beijing, China.
